OPTIME Therapeutics, Inc.
|OPTIME Therapeutics, Inc. Patent applications|
|Patent application number||Title||Published|
|20090196914||LIPOSOMAL L-CARNITINE - The present invention provides liposomal L-carnitine formulations and methods for the treatment of intermittent claudication. The formulation is optimized with respect to L-carnitine transport through skin in vitro. Preferably, the formulation is a topical cream for the administration of the drug directly on the muscle group that is most affected by the poor local blood flow.||08-06-2009|